Joseph Jorizzo to Lupus Erythematosus, Cutaneous
This is a "connection" page, showing publications Joseph Jorizzo has written about Lupus Erythematosus, Cutaneous.
Connection Strength
0.932
-
Shipman WD, Vernice NA, Demetres M, Jorizzo JL. An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review. J Am Acad Dermatol. 2020 Mar; 82(3):709-722.
Score: 0.709
-
Ro T, Tull RZ, Cardwell LA, Farhangian ME, Moustafa F, Richardson I, Jorizzo JL, Feldman S, Huang W. A Pilot Study Characterizing Factors in Adherence to Cutaneous Lupus Treatment. J Cutan Med Surg. 2018 Sep/Oct; 22(5):530-532.
Score: 0.167
-
Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PG. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol. 2003 Jan; 139(1):50-4.
Score: 0.056